Pharmacology - 07:01
FDA grants Breakthrough Therapy Designation for Roche’s Gazyva (obinutuzumab) in Lupus Nephritis
FDA grants Breakthrough Therapy Designation for Roche’s Gazyva (obinutuzumab) in Lupus Nephritis
Pharmacology - Sep 17
Novartis Cosentyx positive 16-week PREVENT results advance potential new indication for patients with axial spondyloarthritis
Novartis Cosentyx positive 16-week PREVENT results advance potential new indication for patients with axial spondyloarthritis
wire - news in brief
Category
Results 101 - 150 of 339.
Roche’s Tecentriq plus platinum-based chemotherapy reduced the risk of disease worsening or death in people with previously untreated advanced bladder cancer
IMvigor130 is the first positive Phase III study of a cancer immunotherapy combination in previously untreated advanced bladder cancer Data will be shared with health authorities globally, including
IMvigor130 is the first positive Phase III study of a cancer immunotherapy combination in previously untreated advanced bladder cancer Data will be shared with health authorities globally, including
Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc
Roche and Spark Therapeutics, Inc.
Roche and Spark Therapeutics, Inc.
(Summer Series): Mathieu Clavel, a master's student in the College of Humanities (CDH) Digital Humanities Institute, is bringing musical heritage from Afghanistan to life using tools from data science and virtual reality.
The ETH Zurich Zentrum and Hönggerberg campuses are not just the study and office spaces of the 30,000 members of ETH: they are also home to a variety of animals and plants.
Novartis receives positive CHMP opinion for Lucentis treatment
Lucentis (ranibizumab), if approved in the EU for this indication, will be the first and only pharmacological therapy for ROP in these vulnerable infants Positive opinion is based on the landmark Pha
Lucentis (ranibizumab), if approved in the EU for this indication, will be the first and only pharmacological therapy for ROP in these vulnerable infants Positive opinion is based on the landmark Pha
CHMP recommends EU approval of Roche’s Tecentriq in combination with chemotherapy
Decision based on results from first Phase III study to show a cancer immunotherapy-based combination significantly improved overall survival (OS) and progression-free survival (PFS) in over 20 years
Decision based on results from first Phase III study to show a cancer immunotherapy-based combination significantly improved overall survival (OS) and progression-free survival (PFS) in over 20 years
Empa and the Korean Institute of Civil Engineering and Building Technology (KICT) are committed to working together for a sustainable and networked society.
At yesterday's Hyperloop Competition in Los Angeles, the Swissloop pod achieved a top speed of 252 km/h.
Using similar propulsion technology, the Hyperloop pods developed by EPFL and ETH Zurich turned in a solid performance in Los Angeles: EPFLoop topped out at 238 km/h in the airless tube set up by SpaceX, while Swissloop peaked at 259km/h.
DNA has become the icon of modern bioscience but few people realize that it was Friedrich Miescher, who - almost a century before Watson and Crick - laid the chemical groundwork for the molecular breakthroughs that followed. Today, 150 years after Miescher's first ‘discovery' of DNA, we want to highlight his remarkable work.
The finals of the SpaceX Hyperloop Pod Competition will take place this Sunday. The crowning race will play out in an airless tube, and EPFL's student team is among the top three contenders.
EPFL startup develops innovative method for recycling PET
DePoly, a startup based at EPFL's Valais-Wallis campus, has developed a chemical-based method for recycling PET containers.
DePoly, a startup based at EPFL's Valais-Wallis campus, has developed a chemical-based method for recycling PET containers.
Evaluating the risks posed by synthetic biology
Last week, nearly 70 experts from around the world gathered at EPFL for a workshop on potential threats arising from synthetic biology.
Last week, nearly 70 experts from around the world gathered at EPFL for a workshop on potential threats arising from synthetic biology.
FDA accepts file and accelerates review of Novartis sickle cell disease medicine crizanlizumab (SEG101)
FDA grants crizanlizumab Priority Review based on Phase II data showing prevention of vaso-occlusive crises (VOCs) in patients with sickle cell disease, shortening FDA review to six months from stand
FDA grants crizanlizumab Priority Review based on Phase II data showing prevention of vaso-occlusive crises (VOCs) in patients with sickle cell disease, shortening FDA review to six months from stand
Sustainable means of mobility are becoming ever more popular. In Switzerland, around 15,000 people have registered with the online platform carvelo2go, which hires out electric cargo bikes.
Roche presents a broad range of data for Hemlibra demonstrating continued benefits for people with haemophilia A at the ISTH 2019 Congress
New analyses from phase III HAVEN studies support Hemlibra's sustained efficacy, safety and quality of life benefit in people with haemophilia A, with and without factor VIII inhibitors First data of
New analyses from phase III HAVEN studies support Hemlibra's sustained efficacy, safety and quality of life benefit in people with haemophilia A, with and without factor VIII inhibitors First data of
Emmanuel Abbé is the new Chair of Mathematical Data Science at EPFL. His work answers fundamental questions in machine learning and information theory, and in particular on community detection. Sociologists study the patterns of everyday social interactions and relationships by structuring society in a network.
To harvest wind energy, you don't necessarily need rotors on steel masts - light kites on thin ropes can do the same. The Empa spin-off TwingTec has been researching this technology for some time now. Last autumn, it was possible for the first time to start, generate electrical energy while flying and then land again, all in the specified level of automation.
Ready to recycle?
The number of registrations of electric cars is rising sharply. But where to put old batteries' The association of Swiss car importers, "auto-schweiz", is striving for a recycling solution for the entire industry.
The number of registrations of electric cars is rising sharply. But where to put old batteries' The association of Swiss car importers, "auto-schweiz", is striving for a recycling solution for the entire industry.
A new Empa study shows how much work still lies ahead of us if Switzerland is to do without fossil fuels in the future. There are two possible solutions: storing large amounts of energy in summer and limiting our demand in winter, or generating energy in the "sunny south" or "windy north" of the world and transporting it here.
How to make Switzerland CO2-free
Switzerland is about to undergo a comprehensive transformation of its energy system if it plans to drastically curb its CO2 emissions.
Switzerland is about to undergo a comprehensive transformation of its energy system if it plans to drastically curb its CO2 emissions.
Never before has such an efficient flexible CIGS solar cell been built. Empa researchers achieve an efficiency of 20.8% - breaking their own record.
Pharmacology - 07:01
FDA grants Breakthrough Therapy Designation for Roche’s Gazyva (obinutuzumab) in Lupus Nephritis
FDA grants Breakthrough Therapy Designation for Roche’s Gazyva (obinutuzumab) in Lupus Nephritis
Pharmacology - Sep 17
Novartis Cosentyx positive 16-week PREVENT results advance potential new indication for patients with axial spondyloarthritis
Novartis Cosentyx positive 16-week PREVENT results advance potential new indication for patients with axial spondyloarthritis